Literature DB >> 17593624

Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cells.

P Dowling1, P Maurya, P Meleady, S A Glynn, A J Dowd, M Henry, M Clynes.   

Abstract

BACKGROUND: Selection of the human drug sensitive and invasive cell line (MDA-MB-435S-F) with the chemotherapeutic agent paclitaxel, resulted in the development of drug resistant cell lines displaying enhanced invasion-related characteristics.
MATERIALS AND METHODS: Serum-free conditioned media from the human cancer drug-sensitive and invasive cell line (MDA-MB-435S-F) and its paclitaxel-resistant superinvasive variant (MDA-MB-435S-F/Taxol10p4pSI) were analyzed using Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS).
RESULTS: A differentially expressed protein was observed at 7.6 kDa, which was 4-fold up-regulated in MDA-MB-435S-F/Taxol10p4pSI. The differentially expressed protein was identified using matrix-assisted laser desorption ionization tandem time-of-flight mass spectrometry (MALDI-TOF/TOF MS), as a fragment of bovine transferrin. The transferrin receptor was also found to be overexpressed in the superinvasive cell line.
CONCLUSION: Cleavage of serum proteins such as transferrin could provide a valuable source of markers for malignant tumours and could also play a role in aspects of cancer pathogenesis, such as tumour cachexia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593624

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Clinical proteomics of breast cancer.

Authors:  Y Baskın; T Yiğitbaşı
Journal:  Curr Genomics       Date:  2010-11       Impact factor: 2.236

Review 2.  Applications of SELDI-MS technology in oncology.

Authors:  L C Whelan; K A R Power; D T McDowell; J Kennedy; W M Gallagher
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.